𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autoantibodies against gp140, the Epstein-Barr virus and C3d receptor in sera from rheumatoid arthritis patients

✍ Scribed by Monique Barel; Alice Kahan; Christiane Charriaut-Marlangue; André Kahan; Raymond Frade

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
518 KB
Volume
16
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of anti-epstein-barr-virus tra
Detection of anti-epstein-barr-virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma
✍ Irène Joab; Jean-Claude Nicolas; Guy Schwaab; Guy de-Thé; Bernard Clausse; Miche 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 308 KB 👁 2 views

The Epstein-Barr virus (EBV) is a ubiquitous Herpes virus which causes infectious mononucleosis and is associated with such different neoplasms as Burkitt's lymphoma and nasopharyngeal carcinoma. EBV latently infects its target cells; nevertheless, evidence of viral replication in NPC tumours has be

A Search for Rheumatoid Arthritis-Associ
A Search for Rheumatoid Arthritis-Associated Nuclear Antigen And Epstein-Barr Virus Specific Antigens or Genomes in Tissues and Cells from Patients with Rheumatoid Arthritis
✍ Margaret A. Alspaugh; Hiromu Shoji; Meihan Nonoyama 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Pannus extracts and/or cells and tissues from rheumatoid arthritis (RA) patients and controls were tested for the presence of RA-associated nuclear antigen (RANA), anti-RANA, Epstein-Barr virus (EBV)-specific antigens, and EBV genomes. Using our present rather insensitive methods, RANA was rarely de

Correlation between the presence of anti
Correlation between the presence of antibodies to the Epstein-barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis
✍ Thomas B. Sculley; John H. Pope; Ron A. Hazelton 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 643 KB

The incidence of antibodies to Epstein-Barr nucleair antigen type 2 (EBNA-2) was determined in sera from rheumatoid arthritis (RA) patients and control subjects, by protein immunoblotting. Sixty-eight percent of the RA patients and 48% of the controls possessed anti-EBNA-2 antibodies. The titer of a